Welcome to our dedicated page for Ufp Technologies SEC filings (Ticker: UFPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UFP Technologies Inc. filings document operating results and material events for its medical-device contract development and manufacturing business. Form 8-K reports furnish quarterly and annual earnings releases, non-GAAP financial measures, Regulation FD investor presentation materials, material definitive agreements with strategic medical customers, cybersecurity incident disclosures, and executive succession and compensation arrangements.
Proxy filings cover board elections, executive compensation, equity awards, pay-versus-performance disclosure, and shareholder voting matters. These records frame the company's governance, capital and incentive structure, customer-contract disclosures, and public reporting obligations as a Nasdaq-listed operating company.
Hudson Symeria reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies director Symeria Hudson received a grant of 802 restricted stock units (RSUs) of Common Stock as director compensation. These RSUs were issued at no cash cost under the company’s 2009 Non-Employee Director Stock Incentive Plan and will settle in shares of Common Stock.
The grant vests in full on May 31, 2027, as long as Hudson continues to serve as a director through that date. After this award, Hudson’s reported direct holdings total 1,955 shares of Common Stock, reflecting a relatively small, routine equity-based compensation grant.
FELDMANN CYNTHIA L reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies director Cynthia L. Feldmann reported an equity award of 802 restricted stock units. These units were granted at no cash cost under the company’s 2009 Non-Employee Director Stock Incentive Plan and will be settled solely in shares of Common Stock.
The award vests in full on May 31, 2027, if she continues serving as a director through that date. Following this grant, Feldmann holds 5,476 shares of Common Stock directly, giving her additional long-term, stock-based exposure to the company’s performance.
CROTEAU DANIEL C reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies director Daniel C. Croteau received an equity award of 802 restricted stock units of Common Stock. These units were granted at no cash cost to him under the company’s 2009 Non-Employee Director Stock Incentive Plan and will settle solely in shares of Common Stock. The award vests in full on May 31, 2027, provided he continues serving as a director through that date. After this grant, he holds a total of 1,657 shares of UFP Technologies common stock directly.
OBERDORF THOMAS reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies director Thomas Oberdorf received an equity grant of 802 restricted stock units (RSUs) of Common Stock at no cash cost, as director compensation. The RSUs were issued under the company’s 2009 Non-Employee Director Stock Incentive Plan.
The award vests in full on May 31, 2027, provided he continues to serve as a director through that date. After this grant, Oberdorf holds a total of 13,219 shares of UFP Technologies common stock directly.
KOZIN MARC D reported acquisition or exercise transactions in this Form 4 filing.
UFP Technologies director Marc D. Kozin received an equity award in the form of restricted stock units. He was granted 802 RSUs that will be settled in shares of common stock under the company’s 2009 Non-Employee Director Stock Incentive Plan.
The units vest 100% on May 31, 2027, as long as he continues serving as a director through that date. After this grant, he holds a total of 28,112 shares of UFP Technologies common stock directly.
UFP Technologies, Inc. reported results of its June 4, 2026 Annual Meeting of Stockholders. Stockholders elected seven directors to serve until the 2027 annual meeting, including Symeria Hudson with 6,591,509 votes for and 87,556 votes withheld, with 423,120 broker non-votes recorded for each nominee.
Stockholders also approved, on a non-binding advisory basis, the Company’s executive compensation, with 5,971,694 votes for, 664,037 against, 43,334 abstentions and 423,120 broker non-votes. In addition, they ratified the appointment of Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026, with 7,029,294 votes for, 69,957 against and 2,934 abstentions.
UFP Technologies, Inc. disclosed that its General Counsel, Secretary, and Senior Vice President of Human Resources, Christopher P. Litterio, plans to retire from the company after a transition period. The filing indicates a planned leadership change in the company’s legal and human resources functions rather than an immediate departure.
UFP Technologies director Daniel C. Croteau reported an open-market sale of 2,864 shares of Common Stock at $221.71 per share. The transaction involved non-derivative common stock and left him with 855 shares held directly following the sale.
UFP Technologies director Daniel C. Croteau exercised stock options to acquire 2,864 shares of common stock at $22.02 per share. Following the transaction, he directly holds 3,719 shares of UFP Technologies common stock. This filing reflects a derivative exercise rather than an open-market purchase or sale.